Basics Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests. IPO Date: September 20, 2017 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $2.36B Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 2.96% Avg Daily Range (30 D): $1.51 | 3.32% Avg Daily Range (90 D): $0.70 | 2.62% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): 1.91M Avg Daily Volume (90 D): .74M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 57 Institutional Trades Total Inst.Trades: 440 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $2.2M Avg Inst. Trade (90 D): $2.16M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.77M Avg Closing Trade (30 D): $3.94M Avg Closing Trade (90 D): $3.55M Avg Closing Volume: 137.84K     News Jul 29, 2025 @ 7:46 PM Biotech Underdogs Line Up for Pivotal Shots at Gam... Source: Prnewswire Jul 8, 2025 @ 2:25 PM Amid NCI Budget Fears, Emerging Oncology Stocks Ga... Source: Prnewswire Feb 27, 2025 @ 3:04 PM Oncology Breakthroughs: How Cancer Research Is Adv... Source: Prnewswire Jun 3, 2024 @ 8:01 PM Celcuity To Participate in Jefferies Global Health... Source: Celcuity Inc. May 30, 2024 @ 11:36 AM Celcuity Announces Pricing of Underwritten Common ... Source: Celcuity Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.47 $-1.04 $-.86 Diluted EPS $-3.47 $-1.04 $-.86 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -148.71M $ -45.27M $ -37M Operating Income / Loss $ -146.63M $ -44.01M $ -36.13M Cost of Revenue $ $ $ Net Cash Flow $ 15.9M $ 29.88M $ -6.04M PE Ratio